Type 2 diabetes mellitus (T2DM) carries a higher risk of morbidity and it is the leading cause of kidney failure, lower-limb amputations, and new cases of adult blindness. T2DM is one of the leading causes of death around the globe. Several therapeutic classes of non-insulin hypoglycemic medications are commonly strategized in a careful way to manage hyperglycemia in patients with T2DM.
Appropriate selection of treatment is based primarily on patient variables in addition to clinical data. Therefore, it should be individualized, with an emphasis placed on minimizing toxicity while enhancing efficacy. For effective management of diabetes mellitus, Team Docplexus presents you with the Patient Education Kit: Management Of T2DM To download the kit, Click Here.
